reported that loss of Nfkb1 in mouse promoted ageing-related chronic liver disease, featured by steatosis, hepatitis, fibrosis and HCC (80), which point to the possible relevance of polymorphisms in human NFKB1 gene as a risk factor for the progression of inflammatory disease (81). The gene discussed is NFKB1; the disease is steatosis.